The molecular and cellular basis of corticosteroid resistance

Journal of Endocrinology

Volumn 179, Issue 3, 2003, Pages 301-310

  Chikanza, I C ^a   Kozaci, D ^a   Chernajovsky, Y ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; CORTICOSTEROID; CORTICOSTEROID RECEPTOR; CYTOKINE; HORMONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; PREDNISOLONE; TRANSCRIPTION FACTOR AP 1;

ASTHMA; CORTICOSTEROID THERAPY; CYTOKINE RELEASE; DRUG MECHANISM; DRUG RESISTANCE; DRUG RESPONSE; DRUG SENSITIVITY; ENTERITIS; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; IMMUNOPATHOLOGY; IN VITRO STUDY; INFLAMMATORY DISEASE; LYMPHOCYTE PROLIFERATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; CYTOKINES; DRUG RESISTANCE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; SIGNAL TRANSDUCTION;

EID: 0347917308     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1790301     Document Type: Review

References (55)

1. Akerblom IE, Slater EP, Beato M, Baxter JD & Mellon PL 1988 Negative regulation by glucocorticosteroids through interference with cAMP response enhancer. Science 241 350-353.
2. Akira S, Hirano T, Taga T & Kishimoto T 1990 Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB Journal 4 2860-2872.
3. Ali S 1998 Prolactin receptor regulates STAT5 tyrosine phosphorylation and nuclear translocation by two separate pathways. Journal of Biological Chemistry 273 7709-7716.
4. Almawi Y, Lipman ML, Stevens AC, Zanker B, Had ET & Strom TB 1991 Abrogation of glucocorticoid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6 and INFγ. Journal of Immunology 146 3523-3527.
5. Al-Sakkaf KA, Dobson PRM & Brown BL 1996 Activation of phosphatidylinositol-3-OH kinase by prolactin in Nb2 cells. Biochemical and Biophysical Research Communications 221 779-784.
6. Auphan N, Didonato JA, Posette C, Helmberg A & Karin M 1995 Immunosuppression by glucocorticosteroids: inhibition of NF-κB activity through induction of IκBα synthesis. Science 270 286-290.
7. Ayabe T, Ashida T, Taniguchi M, Nomura M, Einami K, Taruishi M, Saitoh Y, Santos SB, Ono M, Shibata Y et al. 1997 A pilot study of centrifugal leukocyte apheresis for corticosteroid resistant active ulcerative colitis. Internal Medicine (Tokyo) 36 322-326.
8. Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, Gemsa D, Donnely T & Bucala R 1996 An essential regulatory role for macrophage inhibitory factor in T cell activation. PNAS 93 7849-7854.
9. Baeuerle PA & Baltimore D 1988 IκBα: a specific inhibitor of the NF-κB transcription factor. Science 242 540-546.
10. Bazan JF 1990 Haematopoietic receptors and helical cytokines. Immunology Today 11 350-354.
11. Beato M 1989 Gene regulation by steroid hormones. Cell 56 335-344.
12. Berlanga JJ, Gualillo O, Buteau H, Applant M, Kelly PA & Edery M 1997 Prolactin activates trysosyl phosphorylation of insulin receptor substrate and phosphatidylinositol-3-OH kinase. Journal of Biological Chemistry 272 2050-205.
13. Bernton EW, Meltzer MS & Holaday JW 1988 Suppression of macrophage activation and T lymphocyte function in hypoprolactinemic mice. Science 239 401-404.
14. Burns K, Duggan B, Atkinson E, Famulski K, Nemer M, Bleackley C & Michlak M 1994 Modulation of gene expression by calreticulin binding to the glucocrticosteroid receptor. Nature 367 476-483.
15. Calandra T & Bucala R 1997 Macrophage inhibitory factor: a glucocorticoid counter-regulator within the immune system. Critical Reviews in Immunology 17 77-88.
16. Castro M, Elliot S, Kino T, Bamberger C, Karl M, Webster E & Chrousos GP 1996 The non-ligand binding β-isoform of the human glucocorticosteroid receptor: tissue levels, mechanisms of action and potential physiologic role. Molecular Medicine 2 597-607.
17. Cato ACB & Wade E 1996 Molecular mechanisms of anti-inflammatory action of glucocorticosteroids. Bio Essays 18 371-378.
18. Cesario TC, Yousefi S, Carandana G, Sadati N, Le J & Vaziri N 1994 Enhanced yields of gamma interferon in prolactin treated human peripheral blood mononuclear cells. Proceedings of the Society for Experimental Biology and Medicine 205 89-95.
19. Chikanza IC 1999 Prolactin and neuroimmunomodulation: in vitro and in vivo observations. Annals of the New York Academy of Sciences 876 131-144.
20. Chikanza IC & Grossman A 1996 Neuroendocrine immune responses to inflammation: the concept of the neuroendocrine immune loop. Balliere's Clinical Rheumatology 10 199-226.
21. Chikanza IC & Grossman AS 2000 Reciprocal interactions between the neuroendocrine and immune systems. Rheumatic Diseases Clinics of North America 26 693-712.
22. Chikanza IC & Panayi GS 1993 The differential effects of hydrocortisone on in vitro lymphocyte proliferation, IL-2, IL-4 production in corticosteroid sensitivity and resistant rheumatoid patients. European Journal of Clinical Investigation 23 845-850.
23. Chikanza IC, Pearce GJ & McCloskey DJ 2000 NF-κB activity in vivo is significantly upregulated in corticosteroid resistant rheumatoid arthritis patients. Rheumatology 39 (Suppl 1) 4.
24. Chikanza IC, Kozaci D & Chernajovsky Y 2003 Up-regulation of macrophage inhibitory factor in corticosteroid resistant patients with rheumatoid arthritis. Rheumatology 42 29.
25. Chrousos GP, Vingerhoeds A, Brandon D, Eil C, Pugeat M, DeVroede M, Loriaux DL & Lipsett MB 1982 Primary cortisol resistance in man: a glucocorticoid receptor-mediated disease. Journal of Clinical Investigation 69 1261-1269.
26. Clevenger CV & Medaglia MV 1994 The protein tyrosine kinase p56 fyn is associated with prolactin receptor and is activated by prolactin stimulation of T-lymphocytes. Molecular Endocrinology 6 674-681.
27. Clevenger CV, Russell DH, Appasamy PM & Prytowsky MB 1990 Regulation of IL-2 driven T-lymphocyte proliferation by prolactin. PNAS 87 6460-6464.
28. Clevenger CV, Altmann SW & Prystowsky MB 1991 Requirement of nuclear prolactin for interleukin 2 stimulated proliferation of T lymphocytes. Science 253 77-79.
29. Dardenne M, de Moraes Mdo C, Kelly PA & Gagnerault MC 1994 Prolactin receptor expression in human hematopoietic tissues analyzed by flow cytofluorimetry. Endocrinology 134 2108-2214.
30. Dedhars S, Rennie PS, Shago M, Hagesteijin CYL, Yang H, Filmus J, Hawley RG, Bruchovsky N, Cheng H, Matusik RJ et al. 1994 Inhibition of nuclear hormone receptor activity by calreticulin. Nature 367 480-483.
31. Encio IJ & Detera-Wadleigh SD 1991 The genomic structure of the human glucocorticosteroid receptor. Journal of Biological Chemistry 266 7182-7188.
32. Erwin RA, Kirken RA, Malbara MG, Farrar WL & Rui H 1995 Prolactin activates Ras via signalling proteins SHC, growth factor receptor bound 2, and son of sevenless. Endocrinology 136 3512-3518.
33. Gouilleux F, Moritz D, Humar M, Moriggl R, Berchtold S & Groner B 1995 Prolactin and interleukin 2 receptors in T lymphocytes signal through a MGF-STAT5 like transcription factor. Endocrinology 136 5700-5708.
34. Hawrylowicz C, Richards D, Loke TK, Corrigan C & Lee T 2002 A defect in corticosteroid-induced IL-10 production in T lymphocytes from corticosteroid-resistant asthmatic patients. Journal of Allergy and Clinical Immunology 109 369-370.
35. Hecht K, Carlstedt DJ, Stierna P, Gustafsson J, Bronnegard M & Wikstrom AC 1997 Evidence that the beta isoform of the human glucocorticoid receptor does not act as a physiologically significant repressor. Journal of Biological Chemistry 272 26659-26664.
36. Hou J, Schindler U, Henzel WJ, Wong SE & McKnight SC 1995 Identification and purification of human STAT proteins activated in response to IL-2. Immunity 2 321-329
37. Huizenga NA, de Lange P, Koper JW, de Herder WW, Abs R, Kasteren JH, de Jong FH & Lamberts SW 2000 Five patients with biochemical and/or clinical generalized glucocorticoid resistance without alterations in the glucocorticoid receptor gene. Journal of Clinical Endocrinology and Metabolism 85 2076-2081.
38. Ihle JN 1996 STATs: Signal transducers and activation of transcription. Cell 84 331-334.
39. Kam JC, Szfler SJ, Surs W, Sher ER & Leung DYM 1993 Combination of IL-2 and IL-4 reduces glucocorticoid receptor binding affinity and T cell response to glucocorticoids. Journal of Immunology 151 3460-3466.
40. Karin M 1995 The regulation of AP-1 activity by mitogen activated protein kinases. Journal of Biological Chemistry 270 16483-16486.
41. Kelley KW, Brief S, Westly HJ, Novakofski J, Bechtel PJ, Simon J & Walker EB 1986 GH3 pituitary adenoma can reverse thymic ageing in rats. PNAS 83 5653-5657.
42. de Lange P, Koper JW, Brinkmann AO, de Jong FH & Lamberts SW 1999 Natural variants of the beta isoform of the human glucocorticoid receptor do not alter sensitivity to glucocorticoids. Molecular and Cellular Endocrinology 153 163-168.
43. Leung DY, Hamid Q, Vottero A, Szefler SJ, Surs W, Minshall E, Chrousos G & Klemm D 1997 Association of glucocorticosteroid insensitivity with increased expression of glucocorticosteroid receptor β. Journal of Experimental Medicine 186 1567-1574.
44. Li B, Subleski M, Fusaki Ni, Yamamoto T, Copeland T, Princler GL, Kung H & Kamata T 1996 Catalytic activity of the mouse guaninine nucleotide exchanger mSOS is activated by Fyn tyrosine protein kinase and the T cell antigen receptor in T cells. PNAS 93 1001-1005.
45. Lipsett MB, Tomita M, Brandon DD, De Vroede MM, Loriaux DL & Chrousos GP 1986 Cortisol resistance in man. In Steroid Hormone Resistance: Mechanisms and Clinical Aspects, pp 97-109. Eds GP Chrousos, DL Loriaux & MB Lipsett. New York, NY: Plenum Press.
46. Matera L, Cesano A, Bellone G & Oberholtzer L 1992 Modulatory effect of prolactin on the resting and mitogen induced activity of T, B and NK lymphocytes. Brain, Behaviour and Immunity 6 409-417.
47. May M & Ghosh S 1999 IκB kinases: kinsmen with different crafts. Science 284 271-273.
48. Sabharwal P, Glaser K, Lafuse W, Varma S, Liu Q, Atkins S, Kooijman R, Kutz L, Kelley KW & Malarkey WB 1992 Prolactin synthesized and secreted by human peripheral blood mononuclear cell and autocrine growth factor for lymphoproliferation. PNAS 89 7713-7716.
49. Sandi C, Cambronero JC, Borrell J & Guaza C 1992 Mutually antagonistic effects of corticosterone and prolactin on rat lymphocyte proliferation. Neuroendocrinology 56 574-581.
50. Scheinman RI, Cogswell PC, Lofquist AK & Baldwin AS 1995 Role of transcriptional activation of IκBα in the mediation of immunosuppression by glucocorticosteroids. Science, 270 283-286.
51. Sher ER, Leung DY, Surs W, Kam JC, Kamada AK & Szefler SJ 1994 Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. Journal of Clinical Investigation 93 33-39.
52. Stocklin E, Wissler M, Gouilleux F & Groner B 1996 Functional interactions between STAT5 and the glucocorticoid receptor. Nature 383 726-728.
53. Vingerhoeds ACM, Thijssen JHH & Schwarz F 1976 Spontaneous hypercortisolism without Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 43 1128-1133.
54. Witorsch R-J, Day EB, Lavoie HA, Hashemi N & Taylor NK 1993 Comparison of the glucocorticoid-induced effects in prolactin dependent and autonomous rat Nb2 lymphoma cells. Proceedings of the Society for Experimental Biology and Medicine 203 454-460.
55. Wu J, Cunha FQ, Liew FY & Weiser W 1993 IL-10 synthesis inhibits the synthesis of MIF and MIT-mediated macrophage activation. Journal of Immunology 151 4325-4332.